AKT1 and ovarian carcinoma: Crucially, experimental validation demonstrated that TWP simultaneously modulates these targets to coordinately suppress PI3K-AKT, JAK-STAT, and ERK-MAPK signaling pathways, thereby inducing apoptosis and overcoming cisplatin resistance in ovarian cancer cells.